Latest From HeartFlow Inc.
Medtech Insight's Results Recap is a regular feature covering the major device trial results compiled by MedDeviceTracker. This is the third of three Results Recaps covering trial data presented at the American College of Cardiology Scientific Sessions in New Orleans, March 16-18, including the final results of the MOMENTUM 3 trial of Abbott’s HeartMate 3 left-ventricular assist device and six-month results from the RADIANCE-HTN SOLO trial of ReCor’s Paradise renal denervation system, and more. Check out Part I and Part II of our ACC Results Recap.
GNS Healthcare wants to be on the forefront of the digital revolution in health care by offering its artificial intelligence powers to pharmaceutical and health-insurer customers to help them find the drivers of health outcomes and save costs along the way. It has also teamed up with research and patient foundations to expedite the R&D process, predict best treatment options for patients and create efficiencies for clinical trials.
UK Innovation, EU Regulation And Digital Transformation Are Top Themes For Medtechs At NHS Expo 2018
NHS England chief Simon Stevens has a habit of stealing headlines in UK health-care circles, and his CAR-T cell therapy approval announcement did the trick at the NHS 2018 Innovation Expo. But medtech innovation schemes and furthering the UK digital agenda emerged as main talking points at the meeting.
The global market for diagnostic and guided interventional cardiology products is expected to reach $4.8bn by 2021, and is driven in large part by the rising elderly population and increasing burden of cardiovascular disease (CVD). Meddevicetracker expects that intracardiac echocardiography (ICE), guide wire-based intravascular stenosis assessment (FFR) and optical coherence tomography (OCT) systems will drive overall market growth, given their high demand, which is supported by clinical evidence needed to bring cost savings and improved outcomes. Physicians' preference for using noninvasive and minimally invasive diagnostic techniques in cases where results are inconclusive is also changing the landscape of innovation. In this feature, we'll take a closer look at the overall market and its regional perspective, the competitive landscape of the three fastest-growing segments ICE, FFR and OCT, and the latest emerging technologies, as well as provide insight into what physicians think of these technologies.
Diagnostic Imaging Equipment & Supplies
- Diagnostic Imaging Equipment & Supplies
- Therapeutic Areas
- Cardiovascular Simulation Inc.
- North America
- Parent & Subsidiaries
- HeartFlow Inc.
- Senior Management
Dana Mead, Jr., MD, Pres. & CEO
Baird Radford, CFO
Charles A Taylor, PhD, CTO
Campbell Rogers, MD, CMO
Michael Buck, Chief Commercial Officer
Robert Eno, SVP, Mktg.
- Contact Info
Phone: (650) 241-1221
1400 Seaport Blvd., Bldg. B
Redwood City, CA 94063